FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002539-27-FR
Enrollment
Unknown
Registered
2013-04-19
Start date
2013-03-05
Completion date
Unknown
Last updated
2013-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: PT Classification code 10018336 Term: Glioblastoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Interventions

Trade Name: Avastin Product Name: Avastin Pharmaceutical Form: Solution for injection Trade Name: Temodal Pharmaceutical Form: Pillules

Sponsors

CHU Amiens
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 80 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Secondary Objective: ;Primary end point(s): ;Main Objective:—

Countries

France

Contacts

Public ContactAIT AMER MEZIANE Mohamed

CHU Amiens

aitamermeziane.mohamed@chu-amiens.fr33322668060

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026